(Q24303657)

1

0 references

Annique Wilson-Weekes

2

0 references

Gem S Burgess

4

0 references

Carissa A Phillips

5

0 references

Katie J Hincher

6

0 references

Larry D Cripe

7

0 references

H Scott Boswell

The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1

8

0 references

language of work or name

English

0 references

publication date

October 2006

0 references

published in

Experimental Hematology

0 references

volume

34

0 references

page(s)

1360-76

0 references

issue

10

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPHEM.2006.05.019

7 January 2021

Regulation of human glutathione S-transferase pi gene transcription: influence of 5'-flanking sequences and trans-activating factors which recognize AP-1-binding sites

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPHEM.2006.05.019

7 January 2021

Single cell profiling of potentiated phospho-protein networks in cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPHEM.2006.05.019

7 January 2021

Src family tyrosine kinases are activated by Flt3 and are involved in the proliferative effects of leukemia-associated Flt3 mutations

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPHEM.2006.05.019

7 January 2021

Catalytic domains of tyrosine kinases determine the phosphorylation sites within c-Cbl

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPHEM.2006.05.019

7 January 2021

Criteria for analyzing interactions between biologically active agents

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPHEM.2006.05.019

7 January 2021

The mammalian UV response: c-Jun induction is required for exit from p53-imposed growth arrest

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPHEM.2006.05.019

7 January 2021

Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPHEM.2006.05.019

7 January 2021

Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPHEM.2006.05.019

7 January 2021

Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPHEM.2006.05.019

7 January 2021

Probing tumor phenotypes using stable and regulated synthetic microRNA precursors

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPHEM.2006.05.019

7 January 2021

MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPHEM.2006.05.019

7 January 2021

Survival signaling mediated by c-Jun NH(2)-terminal kinase in transformed B lymphoblasts.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPHEM.2006.05.019

7 January 2021

Targeting JNK for therapeutic benefit: from junk to gold?

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPHEM.2006.05.019

7 January 2021

FLT3 signaling in hematopoietic cells involves CBL, SHC and an unknown P115 as prominent tyrosine-phosphorylated substrates

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPHEM.2006.05.019

7 January 2021

Role of the adapter protein CRKL in signal transduction of normal hematopoietic and BCR/ABL-transformed cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPHEM.2006.05.019

7 January 2021

Role for c-jun N-terminal kinase in treatment-refractory acute myeloid leukemia (AML): signaling to multidrug-efflux and hyperproliferation

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPHEM.2006.05.019

7 January 2021

FLT3 receptors with internal tandem duplications promote cell viability and proliferation by signaling through Foxo proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPHEM.2006.05.019

7 January 2021

Identification of novel FLT-3 Asp835 mutations in adult acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPHEM.2006.05.019

7 January 2021

The Bcr-Abl leukemia oncogene activates Jun kinase and requires Jun for transformation

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPHEM.2006.05.019

7 January 2021

SYK is upstream of phosphoinositide 3-kinase in B cell receptor signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPHEM.2006.05.019

7 January 2021

T cell activation induces direct binding of the Crk adapter protein to the regulatory subunit of phosphatidylinositol 3-kinase (p85) via a complex mechanism involving the Cbl protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPHEM.2006.05.019

7 January 2021

Role of p38alpha Map kinase in Type I interferon signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPHEM.2006.05.019

7 January 2021

Role of the p38 mitogen-activated protein kinase pathway in the generation of the effects of imatinib mesylate (STI571) in BCR-ABL-expressing cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPHEM.2006.05.019

7 January 2021

Transforming growth factor-beta1 (TGF-beta)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-beta-activated kinase 1 and mitogen-activated protein kinase kinase 3

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPHEM.2006.05.019

7 January 2021

Regulation of JNK signaling by GSTp

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPHEM.2006.05.019

7 January 2021

A direct interaction between JNK1 and CrkII is critical for Rac1-induced JNK activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPHEM.2006.05.019

7 January 2021

Control of cell cycle progression by c-Jun is p53 dependent

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPHEM.2006.05.019

7 January 2021

Mitogenic signalling and substrate specificity of the Flk2/Flt3 receptor tyrosine kinase in fibroblasts and interleukin 3-dependent hematopoietic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPHEM.2006.05.019

7 January 2021

Loss of oncogenic H-ras-induced cell cycle arrest and p38 mitogen-activated protein kinase activation by disruption of Gadd45a

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPHEM.2006.05.019

7 January 2021

Regulation of MAP Kinase Signaling Modules by Scaffold Proteins in Mammals

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPHEM.2006.05.019

7 January 2021

Acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPHEM.2006.05.019

7 January 2021

SU5416 and SU5614 inhibit kinase activity of wild-type and mutant FLT3 receptor tyrosine kinase

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPHEM.2006.05.019

7 January 2021

FLT3 and MLL intragenic abnormalities in AML reflect a common category of genotoxic stress.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPHEM.2006.05.019

7 January 2021

Biologic and clinical significance of the FLT3 transcript level in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPHEM.2006.05.019

7 January 2021

FLT3 ligand causes autocrine signaling in acute myeloid leukemia cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPHEM.2006.05.019

7 January 2021

Pim-1 is up-regulated by constitutively activated FLT3 and plays a role in FLT3-mediated cell survival

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPHEM.2006.05.019

7 January 2021

RNAi-induced down-regulation of FLT3 expression in AML cell lines increases sensitivity to MLN518.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPHEM.2006.05.019

7 January 2021

AML-associated Flt3 kinase domain mutations show signal transduction differences compared with Flt3 ITD mutations.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPHEM.2006.05.019

7 January 2021

Direct recruitment of CRK and GRB2 to VEGFR-3 induces proliferation, migration, and survival of endothelial cells through the activation of ERK, AKT, and JNK pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPHEM.2006.05.019

7 January 2021

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the Unite

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPHEM.2006.05.019

7 January 2021

A FLT3-targeted tyrosine kinase inhibitor is cytotoxic to leukemia cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPHEM.2006.05.019

7 January 2021

World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EXPHEM.2006.05.019

7 January 2021